COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Daniele Focosi
Institution
Pisa University Hospital
Address
Pisa
Italy
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2006
9
2007
14
2008
13
2009
14
2010
15
2011
9
2012
5
2013
2
2014
10
2015
5
2016
8
2017
5
2018
1
2019
3
2020
8
2021
25
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Novazzi F
,
Genoni A
,
Spezia PG
,
Focosi D
,
Zago C
,
Colombo A
,
Cassani G
,
Pasciuta R
,
Tamborini A
,
Rossi A
,
Prestia M
,
Capuano R
,
Gasperina DD
,
Dentali F
,
Severgnini P
,
Ageno W
,
Gambarini C
,
Stefanelli P
,
Baj A
,
Maggi F
. Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy. Emerg Microbes Infect. 2021 Dec; 10(1):710-712.
PMID:
33739917
.
Citations:
4
Fields:
Com
Communicable Diseases
Translation:
Humans
Baj A
,
Novazzi F
,
Genoni A
,
Ferrante FD
,
Taborelli S
,
Pini B
,
Partenope M
,
Valli M
,
Gasperina DD
,
Capuano R
,
Prestia M
,
Spezia PG
,
Azzi L
,
Focosi D
,
Maggi F
. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution. Emerg Microbes Infect. 2021 Dec; 10(1):1254-1256.
PMID:
34110974
.
Citations:
Fields:
Com
Communicable Diseases
Translation:
Humans
PH
Public Health
Focosi D
,
Macera L
,
Spezia PG
,
Ceccarelli F
,
Lanza M
,
Maggi F
. Molecular validation of pathogen-reduction technologies using rolling-circle amplification coupled with real-time PCR for torquetenovirus DNA quantification. Transfus Med. 2021 Oct; 31(5):371-376.
PMID:
34390068
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cells
Focosi D
,
Franchini M
,
Pirofski LA
,
Burnouf T
,
Fairweather D
,
Joyner MJ
,
Casadevall A
. COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).
PMID:
34452459
.
Citations:
Fields:
Vir
Virology
Translation:
Humans
Cells
Focosi D
,
Navarro D
,
Maggi F
,
Roilides E
,
Antonelli G
. COVID-19 infodemics: the role of mainstream and social media. Clin Microbiol Infect. 2021 Nov; 27(11):1568-1569.
PMID:
34375756
.
Citations:
Fields:
Com
Communicable Diseases
Mic
Microbiology
Translation:
Humans
Baj A
,
Novazzi F
,
Ferrante FD
,
Genoni A
,
Cassani G
,
Prestia M
,
Colombo A
,
Capuano R
,
Zago C
,
Pasciuta R
,
Tamborini A
,
Rossi A
,
Tettamanzi E
,
Catanoso G
,
Focosi D
,
Maffioli L
,
Maggi F
. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy. J Med Virol. 2021 Dec; 93(12):6460-6461.
PMID:
34314049
.
Citations:
4
Fields:
Vir
Virology
Translation:
Humans
Castelli M
,
Baj A
,
Criscuolo E
,
Ferrarese R
,
Diotti RA
,
Sampaolo M
,
Novazzi F
, Dalla Gasperina D,
Focosi D
,
Ferrari D
,
Locatelli M
,
Clementi M
,
Clementi N
,
Maggi F
,
Mancini N
. Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy. Viruses. 2021 07 31; 13(8).
PMID:
34452380
.
Citations:
2
Fields:
Vir
Virology
Translation:
Humans
Tuccori M
,
Convertino I
,
Ferraro S
,
Valdiserra G
,
Cappello E
,
Fini E
,
Focosi D
. An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future. Expert Opin Drug Discov. 2021 12; 16(12):1403-1414.
PMID:
34304682
.
Citations:
Fields:
Che
Chemistry Techniques
Pha
Pharmacology
Translation:
Humans
PH
Public Health
Focosi D
,
Novazzi F
,
Genoni A
,
Dentali F
,
Gasperina DD
,
Baj A
,
Maggi F
. Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19. Emerg Infect Dis. 2021 Oct; 27(10):2728-2731.
PMID:
34314668
.
Citations:
5
Fields:
Com
Communicable Diseases
Translation:
Humans
Focosi D
,
Tuccori M
,
Baj A
,
Maggi F
. SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies. Viruses. 2021 06 23; 13(7).
PMID:
34201767
.
Citations:
6
Fields:
Vir
Virology
Translation:
Humans
Focosi D
,
Carla IM
,
Lanza M
. ABO Blood Group Correlations with Covid-19: Cohort Choice Makes A Difference. Clin Infect Dis. 2021 06 01; 72(11):e919.
PMID:
32997752
.
Citations:
2
Fields:
Com
Communicable Diseases
Translation:
Humans
Focosi D
,
Franchini M
. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations. Expert Rev Vaccines. 2021 May 27; 1-8.
PMID:
34015243
.
Citations:
2
Fields:
All
Allergy and Immunology
Novazzi F
,
Baj A
,
Genoni A
,
Spezia PG
,
Colombo A
,
Cassani G
,
Zago C
,
Pasciuta R
,
Della Gasperina D
,
Ageno W
,
Severgnini P
,
Dentali F
,
Focosi D
,
Maggi F
. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients. J Med Virol. 2021 Sep; 93(9):5648-5649.
PMID:
33969504
.
Citations:
3
Fields:
Vir
Virology
Translation:
Humans
Focosi D
,
Baj A
,
Maggi F
. Is a single COVID-19 vaccine dose enough in convalescents ? Hum Vaccin Immunother. 2021 Sep 02; 17(9):2959-2961.
PMID:
33950788
.
Citations:
5
Fields:
All
Allergy and Immunology
Translation:
Humans
Focosi D
,
Franchini M
. Clinical predictors of SARS-CoV-2 neutralizing antibody titers in COVID-19 convalescents: Implications for convalescent plasma donor recruitment. Eur J Haematol. 2021 Jul; 107(1):24-28.
PMID:
33780551
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Focosi D
,
Maggi F
,
Franchini M
,
Aguzzi A
,
Lanza M
,
Mazzoni A
,
Menichetti F
. Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor-recipient differences in concentration of neutralizing antibodies. Clin Microbiol Infect. 2021 Jul; 27(7):987-992.
PMID:
33878505
.
Citations:
1
Fields:
Com
Communicable Diseases
Mic
Microbiology
Translation:
Humans
Maggi F
,
Rosellini A
,
Spezia PG
,
Focosi D
,
Macera L
,
Lai M
,
Pistello M
,
de Iure A
,
Tomino C
,
Bonassi S
,
Russo P
. Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes. ERJ Open Res. 2021 Apr; 7(2).
PMID:
33850935
.
Citations:
1
Focosi D
,
Genoni A
,
Lucenteforte E
,
Tillati S
,
Tamborini A
,
Spezia PG
,
Azzi L
,
Baj A
,
Maggi F
. Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin. Life (Basel). 2021 Apr 01; 11(4).
PMID:
33915711
.
Citations:
7
Focosi D
,
Franchini M
. COVID-19 convalescent plasma therapy: hit fast, hit hard! Vox Sang. 2021 10; 116(9):935-942.
PMID:
33794556
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Azzi L
,
Focosi D
,
Dentali F
,
Baj A
,
Maggi F
. Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients. Vaccine. 2021 04 28; 39(18):2489-2490.
PMID:
33824042
.
Citations:
2
Fields:
All
Allergy and Immunology
Focosi D
,
Maggi F
. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines. Rev Med Virol. 2021 11; 31(6):e2231.
PMID:
33724631
.
Citations:
17
Fields:
Vir
Virology
Translation:
Humans
Cells
Focosi D
,
Franchini M
. Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency. Transfus Clin Biol. 2021 May; 28(2):132-134.
PMID:
33675992
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
PH
Public Health
Focosi D
,
Tuccori M
,
Franchini M
. The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19. Life (Basel). 2021 Feb 15; 11(2).
PMID:
33671893
.
Citations:
6
Maggi F
,
Novazzi F
,
Genoni A
,
Baj A
,
Spezia PG
,
Focosi D
,
Zago C
,
Colombo A
,
Cassani G
,
Pasciuta R
,
Tamborini A
,
Rossi A
,
Prestia M
,
Capuano R
,
Azzi L
,
Donadini A
,
Catanoso G
,
Grossi PA
,
Maffioli L
,
Bonelli G
. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy. Emerg Infect Dis. 2021 04; 27(4):1249-1251.
PMID:
33567246
.
Citations:
21
Fields:
Com
Communicable Diseases
Translation:
Humans
Focosi D
,
Franchini M
. COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review. Transfus Apher Sci. 2021 Jun; 60(3):103071.
PMID:
33518427
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
Ferraro S
,
Tuccori M
,
Convertino I
,
Valdiserra G
,
Cappello E
,
Maggi F
,
Blandizzi C
,
Focosi D
. Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs. Br J Clin Pharmacol. 2021 05; 87(5):2186-2188.
PMID:
33185930
.
Citations:
1
Fields:
Pha
Pharmacology
Translation:
Humans
Focosi D
,
Farrugia A
. The art of the possible in approaching efficacy trials for COVID19 convalescent plasma. Int J Infect Dis. 2021 Jan; 102:244-246.
PMID:
33130197
.
Citations:
3
Fields:
Com
Communicable Diseases
Translation:
Humans
Focosi D
,
Tuccori M
,
Antonelli G
,
Maggi F
. What is the optimal usage of coronavirus disease 2019 convalescent plasma donations? Clin Microbiol Infect. 2021 Feb; 27(2):163-165.
PMID:
33007479
.
Citations:
3
Fields:
Com
Communicable Diseases
Mic
Microbiology
Translation:
Humans
Focosi D
,
Maggi F
,
Mazzetti P
,
Pistello M
. Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy. Rev Med Virol. 2021 03; 31(2):e2170.
PMID:
33350017
.
Citations:
14
Fields:
Vir
Virology
Translation:
Humans
Animals
PH
Public Health
Focosi D
,
Anderson AO
,
Tang JW
,
Tuccori M
. Convalescent Plasma Therapy for COVID-19: State of the Art. Clin Microbiol Rev. 2020 09 16; 33(4).
PMID:
32792417
.
Citations:
25
Fields:
Mic
Microbiology
Translation:
Humans
PH
Public Health
Tuccori M
,
Convertino I
,
Ferraro S
,
Cappello E
,
Valdiserra G
,
Focosi D
,
Blandizzi C
. The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance. Drug Saf. 2020 08; 43(8):699-709.
PMID:
32572842
.
Citations:
11
Fields:
Dru
Drug Therapy
Tox
Toxicology
Translation:
Humans
Cells
PH
Public Health
Focosi D
. Anti-A isohaemagglutinin titres and SARS-CoV-2 neutralization: implications for children and convalescent plasma selection. Br J Haematol. 2020 08; 190(3):e148-e150.
PMID:
32516462
.
Citations:
14
Fields:
Hem
Hematology
Translation:
Humans
Cells
PH
Public Health
Convertino I
,
Tuccori M
,
Ferraro S
,
Valdiserra G
,
Cappello E
,
Focosi D
,
Blandizzi C
. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients. Crit Care. 2020 06 11; 24(1):331.
PMID:
32527304
.
Citations:
15
Fields:
Cri
Critical Care
Translation:
Humans
Cells
PH
Public Health
Tuccori M
,
Ferraro S
,
Convertino I
,
Cappello E
,
Valdiserra G
,
Blandizzi C
,
Maggi F
,
Focosi D
. Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline. MAbs. 2020 Jan-Dec; 12(1):1854149.
PMID:
33319649
.
Citations:
39
Fields:
All
Allergy and Immunology
Translation:
Humans
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs
Focosi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (142)
Derived automatically from this person's publications.
Torque teno virus
Plasma
Antibodies, Neutralizing
DNA, Viral
Immunization, Passive
Explore
_
Co-Authors (84)
People in Profiles who have published with this person.
Maggi, Fabrizio
Franchini, Massimo
Tuccori, Marco
Baj, Andreina
Ferraro, Sara
Explore
_
Similar People (60)
People who share similar concepts with this person.
Maggi, Fabrizio
Navarro, David
Albert, Eliseo
Xia, Ningshao
Franchini, Massimo
Explore
_